Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ziekenhuisapotheek Meppel-Hoogeveen (ZAMH) is a specialized hospital pharmacy foundation that provides comprehensive pharmaceutical care to healthcare institutions in the Drenthe and Overijssel regions of the Netherlands. The organization is responsible for the procurement, distribution, and clinical oversight of medications for major regional hospitals, including Isala Meppel and Treant Zorggroep. ZAMH operates advanced laboratory and compounding facilities, enabling the preparation of customized sterile and non-sterile medications tailored to individual patient needs. Their clinical pharmacists provide essential services such as therapeutic drug monitoring, medication safety audits, and pharmacotherapy consultations to medical staff. By centralizing pharmaceutical expertise, ZAMH ensures high standards of medication safety and efficiency across the regional healthcare network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziekenhuisapotheek Meppel-Hoogeveen.